Improved Screening Methods for CCR5-Antagonists Use by Ultra Deep Sequencing and Quantitative Population-Based Sequencing Techniques: Analyzes of the Phase III Human Clinical Trials of Maraviroc (08-09).
Improved Screening Methods for CCR5-Antagonists Use by Ultra Deep Sequencing and Quantitative Population-Based Sequencing Techniques: Analyzes of the Phase III Human Clinical Trials of Maraviroc (08-09).
批准号:
172640
负责人:
Harrigan Richard P
金额:
$50.31万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2011-09-01
中文摘要
HAART的终身性质和艾滋病毒迅速变异的能力引起了人们对治疗反应和毒性的决定因素以及耐药性的发展的关注。开发新型抗逆转录病毒非常重要
英文摘要
The life-long nature of HAART and the ability of HIV to mutate rapidly have led to concerns about the determinants of treatment response and toxicity, as well as the development of drug resistance. It is important to develop novel classes of antiretrovira
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral and Human Genetic Predictors of Response to HIV Therapies
-
批准号:264436
-
项目类别:Operating Grants
-
资助金额:$88.76万
-
财政年份:2012
-
负责人:Harrigan Richard P
-
依托单位:
Viral and Human Predictors of Reponses to HIV Therapies
-
批准号:268905
-
项目类别:Salary Programs
-
资助金额:$25.5万
-
财政年份:2012
-
负责人:Harrigan Richard P
-
依托单位:
HIV Drug Resistance: Transitioning to New Sequencing Technologies
-
批准号:182374
-
项目类别:Operating Grants
-
资助金额:$4.59万
-
财政年份:2009
-
负责人:Harrigan Richard P
-
依托单位: